Posted by Michael Wonder on 10 Jun 2021
CyMedica Orthopedics announces FDA clearance for IntelliHab, a novel drug free, non-invasive modality for treatment of knee osteoarthritis pain
9 June 2021 - CyMedica Orthopedics today announced the U.S. FDA has cleared the submission of its latest technology for the management of knee osteoarthritis pain, IntelliHab.
With this clearance, IntelliHab is the only neuromodulation strengthening therapy indicated to treat pain associated with the debilitating osteoarthritis disease.
